428 related articles for article (PubMed ID: 16096758)
1. Redox metals and oxidative abnormalities in human prion diseases.
Petersen RB; Siedlak SL; Lee HG; Kim YS; Nunomura A; Tagliavini F; Ghetti B; Cras P; Moreira PI; Castellani RJ; Guentchev M; Budka H; Ironside JW; Gambetti P; Smith MA; Perry G
Acta Neuropathol; 2005 Sep; 110(3):232-8. PubMed ID: 16096758
[TBL] [Abstract][Full Text] [Related]
2. The epsilon isoform of 14-3-3 protein is a component of the prion protein amyloid deposits of Gerstmann-Sträussler-Scheinker disease.
Di Fede G; Giaccone G; Limido L; Mangieri M; Suardi S; Puoti G; Morbin M; Mazzoleni G; Ghetti B; Tagliavini F
J Neuropathol Exp Neurol; 2007 Feb; 66(2):124-30. PubMed ID: 17278997
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies.
Richard M; Biacabe AG; Streichenberger N; Ironside JW; Mohr M; Kopp N; Perret-Liaudet A
Acta Neuropathol; 2003 Mar; 105(3):296-302. PubMed ID: 12557018
[TBL] [Abstract][Full Text] [Related]
4. Different prion conformers target the olfactory pathway in sporadic Creutzfeldt-Jakob disease.
Zanusso G; Ferrari S; Benedetti D; Sbriccoli M; Rizzuto N; Monaco S
Ann N Y Acad Sci; 2009 Jul; 1170():637-43. PubMed ID: 19686205
[TBL] [Abstract][Full Text] [Related]
5. Cerebral amyloid angiopathy with co-localization of prion protein and beta-amyloid in an 85-year-old patient with sporadic Creutzfeldt-Jakob disease.
Paquet C; Privat N; Kaci R; Polivka M; Dupont O; Haïk S; Laplanche JL; Hauw JJ; Gray F
Acta Neuropathol; 2008 Nov; 116(5):567-73. PubMed ID: 18551298
[TBL] [Abstract][Full Text] [Related]
6. Plaque-type deposition of prion protein in the damaged white matter of sporadic Creutzfeldt-Jakob disease MM1 patients.
Kobayashi A; Arima K; Ogawa M; Murata M; Fukuda T; Kitamoto T
Acta Neuropathol; 2008 Nov; 116(5):561-6. PubMed ID: 18751990
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Dab1 in APP processing and beta-amyloid deposition in sporadic Creutzfeldt-Jakob patients.
Gavín R; Ferrer I; del Río JA
Neurobiol Dis; 2010 Feb; 37(2):324-9. PubMed ID: 19853035
[TBL] [Abstract][Full Text] [Related]
8. Extracellular protein deposition correlates with glial activation and oxidative stress in Creutzfeldt-Jakob and Alzheimer's disease.
Van Everbroeck B; Dobbeleir I; De Waele M; De Leenheir E; Lübke U; Martin JJ; Cras P
Acta Neuropathol; 2004 Sep; 108(3):194-200. PubMed ID: 15221335
[TBL] [Abstract][Full Text] [Related]
9. Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies.
Kitamoto T; Tateishi J; Tashima T; Takeshita I; Barry RA; DeArmond SJ; Prusiner SB
Ann Neurol; 1986 Aug; 20(2):204-8. PubMed ID: 3092727
[TBL] [Abstract][Full Text] [Related]
10. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part II].
Zaborowski A
Psychiatr Pol; 2004; 38(2):297-309. PubMed ID: 15307294
[TBL] [Abstract][Full Text] [Related]
11. Intracerebral distribution of the abnormal isoform of the prion protein in sporadic Creutzfeldt-Jakob disease and fatal insomnia.
Parchi P; Capellari S; Gambetti P
Microsc Res Tech; 2000 Jul; 50(1):16-25. PubMed ID: 10871544
[TBL] [Abstract][Full Text] [Related]
12. Selective PrP-like protein, doppel immunoreactivity in dystrophic neurites of senile plaques in Alzheimer's disease.
Ferrer I; Freixas M; Blanco R; Carmona M; Puig B
Neuropathol Appl Neurobiol; 2004 Aug; 30(4):329-37. PubMed ID: 15305978
[TBL] [Abstract][Full Text] [Related]
13. Toluidine blue-O staining of prion protein deposits.
Sánchez A; Guzmán A; Ortiz A; Rembao D; Espinosa B; Zenteno E; Guevara J
Histochem Cell Biol; 2001 Dec; 116(6):519-24. PubMed ID: 11810193
[TBL] [Abstract][Full Text] [Related]
14. Protease-resistant PrP and PrP oligomers in the brain in human prion diseases after intraventricular pentosan polysulfate infusion.
Honda H; Sasaki K; Minaki H; Masui K; Suzuki SO; Doh-Ura K; Iwaki T
Neuropathology; 2012 Apr; 32(2):124-32. PubMed ID: 21801238
[TBL] [Abstract][Full Text] [Related]
15. Prion disease causes less severe lesions in human hippocampus than other parts of brain.
Kaneko M; Sugiyama N; Sasayama D; Yamaoka K; Miyakawa T; Arima K; Tsuchiya K; Hasegawa K; Washizuka S; Hanihara T; Amano N; Yagishita S
Psychiatry Clin Neurosci; 2008 Jun; 62(3):264-70. PubMed ID: 18588585
[TBL] [Abstract][Full Text] [Related]
16. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
[TBL] [Abstract][Full Text] [Related]
17. Oxidative damage to nucleic acids in human prion disease.
Guentchev M; Siedlak SL; Jarius C; Tagliavini F; Castellani RJ; Perry G; Smith MA; Budka H
Neurobiol Dis; 2002 Apr; 9(3):275-81. PubMed ID: 11950273
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of water channel aquaporin 1 and aquaporin 4 in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP transgenic mice.
Rodríguez A; Pérez-Gracia E; Espinosa JC; Pumarola M; Torres JM; Ferrer I
Acta Neuropathol; 2006 Nov; 112(5):573-85. PubMed ID: 16871401
[TBL] [Abstract][Full Text] [Related]
19. Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob disease.
Freixes M; Rodríguez A; Dalfó E; Ferrer I
Neurobiol Aging; 2006 Dec; 27(12):1807-15. PubMed ID: 16310893
[TBL] [Abstract][Full Text] [Related]
20. Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie.
Snow AD; Wight TN; Nochlin D; Koike Y; Kimata K; DeArmond SJ; Prusiner SB
Lab Invest; 1990 Nov; 63(5):601-11. PubMed ID: 1977959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
